# Neuralink Pursues High-Volume BCI Production and Automated Surgery in 2026

> news · REPORTED · 2026-05-07

Neuralink is advancing plans for high-volume production of its N1 brain-computer interface implant and a nearly fully automated surgical procedure in 2026, following 12 human implants by September 2025. The company received FDA Breakthrough Device Designation for speech restoration and secured a $650 million Series E in June 2025 valuing it at approximately $9 billion.

About Neuralink: Neuralink is a neurotechnology company developing implantable brain-computer interface devices designed to enable paralyzed patients and those with severe neurological conditions to control digital devices using thought alone.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://www.basenor.com/blogs/news/neuralink-in-2026-where-the-brain-computer-interface-stands-today

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.